Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?

Despite Polycystic Ovary Syndrome (PCOS) is a very prevalent disorder among women of reproductive age, there is widespread agreement that until now, no pharmacological options are available to tackle the entire spectrum of clinical manifestations encountered in the clinical practice. Obesity and ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Pugliese, G., de Alteriis, G., Muscogiuri, G., Barrea, L., Verde, L., Zumbolo, F., Colao, A., Savastano, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372121/
https://www.ncbi.nlm.nih.gov/pubmed/37093453
http://dx.doi.org/10.1007/s40618-023-02084-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372121/
https://www.ncbi.nlm.nih.gov/pubmed/37093453
http://dx.doi.org/10.1007/s40618-023-02084-6

Ejemplares similares